National Health Investors Inc: Form 10-Q for the period ended Mar 31, 2024
Filed with the SEC on May 6, 2024 and accepted by EDGAR at May 6, 2024, 16:06 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2024-03-31. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2024-01-01 to 2024-03-31 | $13.3m | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Interest expense | 3 months2024-01-01 to 2024-03-31 | $14.9m | us-gaap:InterestExpense |
| Net income | 3 months2024-01-01 to 2024-03-31 | $30.9m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2024-01-01 to 2024-03-31 | $0.71 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months2024-01-01 to 2024-03-31 | $0.71 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months2024-01-01 to 2024-03-31 | 43,424,550 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 3 months2024-01-01 to 2024-03-31 | $40.8m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Dividends paid | 3 months2024-01-01 to 2024-03-31 | $39.1m | us-gaap:PaymentsOfDividends |
| Cash and equivalents | At period end2024-03-31 | $11.4m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Total assets | At period end2024-03-31 | $2.48bn | us-gaap:Assets |
| Total liabilities | At period end2024-03-31 | $1.21bn | us-gaap:Liabilities |
| Shareholders' equity | At period end2024-03-31 | $1.25bn | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0000877860-24-000047. Last ingested by Listed: Nov 10, 2026, 02:36 ET. Listed shows no prices and gives no investment advice.